Method for treating diabetes using DHEA compounds
US4518595A · kind A · utility
40Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 19, 1983 |
| Grant date | May 21, 1985 |
| Priority date | — |
| Expiry date | Jul 19, 2003 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/565
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Diabetes is treated by orally administering a dehydroepiandrosterone (DHEA) compound selected from the group consisting of DHEA, DHEA sulfate and soluble DHEA compounds. The DHEA compound is preferably administered in finely dispersed form, powdered or solution, mixed with the food diet of the diabetic in a dosage range of up to 0.4% by weight of the food diet. The pharmacological activity and utility of DHEA as a potent anti-diabetic agent and anti-hyperglycemic agent over a variable range of genetic background is documented.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.